General Nurse Practitioner News

NP

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Naldi L et al. – Despite the increased number of new options, the number of head–to–head comparative trials has decreased and most trials focus on short–term effects, probably reflecting the increased influence of industrial sponsorship on the research agenda.

Related Articles

Pediatric psoriasis: an update
Therapeutics and Clinical Risk Management, 10/22/09    Relevance Score: 95%

FDA Approves New Drug to Treat Psoriasis
Internet Source, 11/02/09    Relevance Score: 91%

Study shows major burden of psoriasis
Internet Source, 10/29/09    Relevance Score: 91%

Prevalence of myocardial infarction in patients with psoriasis in central China
Journal of the European Academy of Dermatology and Venereology, 10/27/09    Relevance Score: 91%

Why nail psoriasis remains difficult to treat
Dermatology in Practice, 10/12/09    Relevance Score: 91%

Today in Dermatology...keeping you current

Is Q-Switched Neodymium-Doped Yttrium Aluminium Garnet Laser an Effective Approach to Treat Xanthelasma Palpebrarum? Results from a Clinical Study of 76 Cases
Dermatologic Surgery, 12/11/09

Surgical excision of skin cancer: the importance of training
British Journal of Dermatology, 12/11/09

More than skin deep: the psychosocial impact of acne
Nurse Prescribing, 12/11/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address